|
AU2013201753A1
|
|
Prevention and treatment of ophthalmic complications of diabetes
|
|
AU2013201754A1
|
|
Formulation and method for administration of ophthalmologically active agents
|
|
EP1904108A2
|
|
Ophthalmological formulation comprising methylsulfonylmethane and ciprofloxacin
|
|
US2006177430A1
|
|
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
US2006166879A1
|
|
Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
|
|
US2006172972A1
|
|
Formulation and method for administration of ophthalmologically active agents
|
|
CN1753683A
|
|
Ophthalmic formulation for the prevention and treatment of ocular conditions
|
